These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 7903129)
1. Impairment of T cell receptor-dependent stimulation in CD4+ lymphocytes after contact with membrane-bound HIV-1 envelope glycoprotein. Schwartz O; Alizon M; Heard JM; Danos O Virology; 1994 Jan; 198(1):360-5. PubMed ID: 7903129 [TBL] [Abstract][Full Text] [Related]
2. HIV envelope glycoprotein-induced cell killing by apoptosis is enhanced with increased expression of CD26 in CD4+ T cells. Jacotot E; Callebaut C; Blanco J; Rivière Y; Krust B; Hovanessian AG Virology; 1996 Sep; 223(2):318-30. PubMed ID: 8806567 [TBL] [Abstract][Full Text] [Related]
3. Production of transmembrane and secreted forms of tumor necrosis factor (TNF)-alpha by HIV-1-specific CD4+ cytolytic T lymphocyte clones. Evidence for a TNF-alpha-independent cytolytic mechanism. Liu AY; Miskovsky EP; Stanhope PE; Siliciano RF J Immunol; 1992 Jun; 148(12):3789-98. PubMed ID: 1351088 [TBL] [Abstract][Full Text] [Related]
4. Normal T cell receptor-mediated signaling in T cell lines stably expressing HIV-1 envelope glycoproteins. Tani Y; Tian H; Lane HC; Cohen DI J Immunol; 1993 Dec; 151(12):7337-48. PubMed ID: 7903106 [TBL] [Abstract][Full Text] [Related]
5. An HIV-1 envelope protein vaccine elicits a functionally complex human CD4+ T cell response that includes cytolytic T lymphocytes. Stanhope PE; Liu AY; Pavlat W; Pitha PM; Clements ML; Siliciano RF J Immunol; 1993 May; 150(10):4672-86. PubMed ID: 8097759 [TBL] [Abstract][Full Text] [Related]
6. Human immunodeficiency virus-1 glycoproteins gp120 and gp160 specifically inhibit the CD3/T cell-antigen receptor phosphoinositide transduction pathway. Cefai D; Debre P; Kaczorek M; Idziorek T; Autran B; Bismuth G J Clin Invest; 1990 Dec; 86(6):2117-24. PubMed ID: 1979339 [TBL] [Abstract][Full Text] [Related]
7. Inhibition of CD4+ T cell activation and adhesion by peptides derived from the gp160. Corado J; Mazerolles F; Le Deist F; Barbat C; Kaczorek M; Fischer A J Immunol; 1991 Jul; 147(2):475-82. PubMed ID: 1677023 [TBL] [Abstract][Full Text] [Related]
8. Differential susceptibility to monomeric HIV gp120-mediated apoptosis in antigen-activated CD4+ T cell populations. Tuosto L; Gilardini Montani MS; Lorenzetti S; Cundari E; Moretti S; Lombardi G; Piccolella E Eur J Immunol; 1995 Oct; 25(10):2907-16. PubMed ID: 7589091 [TBL] [Abstract][Full Text] [Related]
9. Different proliferative response of human and chimpanzee lymphocytes after contact with human immunodeficiency virus type 1 gp120. Di Rienzo AM; Furlini G; Olivier R; Ferris S; Heeney J; Montagnier L Eur J Immunol; 1994 Jan; 24(1):34-40. PubMed ID: 8020568 [TBL] [Abstract][Full Text] [Related]
10. N-linked glycans in the CD4-binding domain of human immunodeficiency virus type 1 envelope glycoprotein gp160 are essential for the in vivo priming of T cells recognizing an epitope located in their vicinity. Sjölander S; Bolmstedt A; Akerblom L; Horal P; Olofsson S; Morein B; Sjölander A Virology; 1996 Jan; 215(2):124-33. PubMed ID: 8560759 [TBL] [Abstract][Full Text] [Related]
11. Biological properties of recombinant HIV envelope synthesized in CHO glycosylation-mutant cell lines. Fenouillet E; Miquelis R; Drillien R Virology; 1996 Apr; 218(1):224-31. PubMed ID: 8615025 [TBL] [Abstract][Full Text] [Related]
12. HIV-gp 160-induced T cell-dependent B cell differentiation. Role of T cell-B cell activation molecule and IL-6. Chirmule N; Kalyanaraman VS; Lederman S; Oyaizu N; Yagura H; Yellin MJ; Chess L; Pahwa S J Immunol; 1993 Mar; 150(6):2478-86. PubMed ID: 8450224 [TBL] [Abstract][Full Text] [Related]
13. HIV envelope proteins differentially utilize CXCR4 and CCR5 coreceptors for induction of apoptosis. Yao Q; Compans RW; Chen C Virology; 2001 Jun; 285(1):128-37. PubMed ID: 11414813 [TBL] [Abstract][Full Text] [Related]
14. Studies of the mechanism of cytolysis by HIV-1-specific CD4+ human CTL clones induced by candidate AIDS vaccines. Miskovsky EP; Liu AY; Pavlat W; Viveen R; Stanhope PE; Finzi D; Fox WM; Hruban RH; Podack ER; Siliciano RF J Immunol; 1994 Sep; 153(6):2787-99. PubMed ID: 7915742 [TBL] [Abstract][Full Text] [Related]
15. Are blockers of gp120/CD4 interaction effective inhibitors of HIV-1 immunopathogenesis? Herbeuval JP; Shearer GM AIDS Rev; 2006; 8(1):3-8. PubMed ID: 16736946 [TBL] [Abstract][Full Text] [Related]
16. Apoptosis induced in synchronized human immunodeficiency virus type 1-infected primary peripheral blood mononuclear cells is detected after the peak of CD4+ T-lymphocyte loss and is dependent on the tropism of the gp120 envelope glycoprotein. Lawson VA; Silburn KA; Gorry PR; Paukovic G; Purcell DF; Greenway AL; McPhee DA Virology; 2004 Sep; 327(1):70-82. PubMed ID: 15327899 [TBL] [Abstract][Full Text] [Related]
17. Macrophage-tropic HIV and SIV envelope proteins induce a signal through the CCR5 chemokine receptor. Weissman D; Rabin RL; Arthos J; Rubbert A; Dybul M; Swofford R; Venkatesan S; Farber JM; Fauci AS Nature; 1997 Oct; 389(6654):981-5. PubMed ID: 9353123 [TBL] [Abstract][Full Text] [Related]
18. Mapping of the human immunodeficiency virus type 2 envelope glycoprotein CD4 binding region and fusion domain with truncated proteins expressed by recombinant vaccinia viruses. Otteken A; Voss G; Hunsmann G Virology; 1993 May; 194(1):37-43. PubMed ID: 8480426 [TBL] [Abstract][Full Text] [Related]
19. Autophagy is involved in T cell death after binding of HIV-1 envelope proteins to CXCR4. Espert L; Denizot M; Grimaldi M; Robert-Hebmann V; Gay B; Varbanov M; Codogno P; Biard-Piechaczyk M J Clin Invest; 2006 Aug; 116(8):2161-72. PubMed ID: 16886061 [TBL] [Abstract][Full Text] [Related]
20. Induction of lymphomonocyte activation by HIV-1 glycoprotein gp120. Possible role in AIDS pathogenesis. Capobianchi MR J Biol Regul Homeost Agents; 1996; 10(4):83-91. PubMed ID: 9604776 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]